Alloy Therapeutics has 6 close competitors: HistoSonics, Innovaccer, Neuralink.
Sector, valuation and status for each competitor.
competitor›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
InnovaccerNeuralinkZocdocAbridgeCommureBiopharmaceutical company focused on the discovery and development of differentiated drugs.
Alloy Therapeutics competes with 6 companies here: HistoSonics, Innovaccer, Neuralink, Zocdoc, Abridge, Commure.
Alloy Therapeutics was last valued at $1B . That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The routes section explains what is realistically available for a company at this stage.
No. Alloy Therapeutics is a private company; its shares do not trade on a public exchange.
The last valuation is $1B.
Lead investors for each round are in the funding timeline.
The closest biotech peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
